Publication:
Antenatal Betamethasone Every 12 Hours in Imminent Preterm Labour.

dc.contributor.authorSaldaña-Garcia, Natalia
dc.contributor.authorEspinosa-Fernandez, Maria Gracia
dc.contributor.authorMartinez-Pajares, Jose David
dc.contributor.authorTapia-Moreno, Elias
dc.contributor.authorMoreno-Samos, Maria
dc.contributor.authorCuenca-Marin, Celia
dc.contributor.authorRius-Diaz, Francisca
dc.contributor.authorSanchez-Tamayo, Tomas
dc.date.accessioned2023-05-03T14:05:15Z
dc.date.available2023-05-03T14:05:15Z
dc.date.issued2022-02-24
dc.description.abstractBenefits of antenatal corticosteroids have been established for preterm infants who have received the full course. In imminent preterm labours there is no time to administer the second dose 24 h later. To determine whether the administration of two doses of betamethasone in a 12 h interval is equivalent to the effects of a full maturation. We performed a retrospective cohort study including preterm infants ≤34 weeks gestational age at birth and ≤1500 g, admitted to an NICU IIIC level in a tertiary hospital from 2015 to 2020. The population was divided into two cohorts: complete maturation (CM) (two doses of betamethasone 24 h apart), or advanced maturation (AM) (two doses of betamethasone 12 h apart). The primary outcomes were mortality or survival with severe morbidities. The presence of respiratory distress syndrome and other morbidities of prematurity were determined. These variables were analysed in the neonates under 28 weeks gestational age cohort. Neurodevelopment at 2 years was evaluated with the validated Ages and Stages Questionnaires®, Third Edition (ASQ®-3). Multiple regression analyses were performed and adjusted for confounding factors. A total of 275 preterm neonates were included. Serious outcomes did not show differences between cohorts, no increased incidence of morbidity was found in AM. A lower percentage of hypotension during the first week (p = 0.04), a tendency towards lower maximum FiO2 (p = 0.14) and to a shorter mechanical ventilation time (p = 0.14) were observed for the AM cohort. Similar results were found in the subgroup of neonates under 28 weeks gestational age. There were no differences in cerebral palsy or sensory deficits at 24 months of corrected age, although the AM cohort showed a trend towards better scores on the ASQ3 scale. Administration of betamethasone every 12 h showed similar results to the traditional pattern with respect to mortality and severe morbidities. No deleterious neurodevelopmental effects were found at 24 months of corrected age. Earlier administration of betamethasone at 12 h after the first dose would be an alternative in imminent preterm delivery. Further studies are needed to confirm these results.
dc.description.versionSi
dc.identifier.citationSaldaña-García N, Espinosa-Fernández MG, Martínez-Pajares JD, Tapia-Moreno E, Moreno-Samos M, Cuenca-Marín C, et al. Antenatal Betamethasone Every 12 Hours in Imminent Preterm Labour. J Clin Med. 2022 Feb 24;11(5):1227
dc.identifier.doi10.3390/jcm11051227
dc.identifier.issn2077-0383
dc.identifier.pmcPMC8911008
dc.identifier.pmid35268318
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911008/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2077-0383/11/5/1227/pdf?version=1645698149
dc.identifier.urihttp://hdl.handle.net/10668/21245
dc.issue.number5
dc.journal.titleJournal of clinical medicine
dc.journal.titleabbreviationJ Clin Med
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.page.number10
dc.provenanceRealizada la curación de contenido 10/03/2025
dc.publisherMDPI
dc.pubmedtypeJournal Article
dc.relation.publisherversionhttps://www.mdpi.com/resolver?pii=jcm11051227
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAntenatal corticosteroids
dc.subjectBetamethasone
dc.subjectMortality
dc.subjectNeurodevelopmental
dc.subjectPreterm infant
dc.subjectRespiratory distress syndrome
dc.subject.decsBetametasona
dc.subject.decsMorbilidad
dc.subject.decsRecién nacido
dc.subject.decsEdad gestacional
dc.subject.decsParálisis cerebral
dc.subject.decsAnálisis de regresión
dc.subject.meshInfant, Premature
dc.subject.meshGestational Age
dc.subject.meshPremature Birth
dc.subject.meshCerebral Palsy
dc.subject.meshIntensive Care Units, Neonatal
dc.subject.meshRespiration, Artificial
dc.titleAntenatal Betamethasone Every 12 Hours in Imminent Preterm Labour.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8911008.pdf
Size:
385.59 KB
Format:
Adobe Portable Document Format